SR-33805
SR-33805 is a chemical compound that has been studied for its potential pharmacological effects, particularly in the context of cardiovascular health. It is classified as a calcium channel blocker, which means it can interfere with the movement of calcium ions through calcium channels in the heart and blood vessel walls. This action can lead to a variety of effects, including the relaxation of blood vessels, reduction of blood pressure, and potential anti-anginal effects.
Pharmacology[edit | edit source]
SR-33805 acts primarily by inhibiting the influx of calcium ions through L-type calcium channels. These channels are crucial for the contraction of cardiac and smooth muscle cells. By blocking these channels, SR-33805 can decrease the contractility of the heart muscle and promote vasodilation, which can lower blood pressure and reduce the workload on the heart.
Mechanism of Action[edit | edit source]
The mechanism of action of SR-33805 involves the selective inhibition of L-type calcium channels. These channels are responsible for the rapid influx of calcium ions during the action potential of cardiac and smooth muscle cells. By blocking these channels, SR-33805 reduces intracellular calcium concentrations, leading to decreased muscle contraction.
Therapeutic Uses[edit | edit source]
While SR-33805 has shown promise in preclinical studies, it is not currently approved for clinical use. Its potential therapeutic uses include the treatment of hypertension, angina pectoris, and other cardiovascular conditions where calcium channel blockers are indicated.
Research and Development[edit | edit source]
Research on SR-33805 has primarily focused on its cardiovascular effects. Studies have demonstrated its ability to lower blood pressure in animal models and its potential to improve outcomes in conditions characterized by excessive cardiac workload.
Safety and Efficacy[edit | edit source]
The safety and efficacy of SR-33805 in humans have not been fully established. Clinical trials would be necessary to determine its potential benefits and risks in human populations.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
